Latest News

Shopify's revenue jumped 30% in 2025 with no debt, while Advance Auto Parts is mid-restructuring with a shrinking top line and negative free cash flow.

Investors' intuitions about the impact of political quagmires on Bitcoin need to be tempered with some real data.

Management credits AI tools for productivity gains in the latest quarter.

Valens targets higher-volume markets with new chips and an onsemi tie-up.

Record backlog and revenue growth, but guidance was cut on delays.

KP Tissue (TSE:KPT) reported higher third-quarter revenue and earnings at Kruger Products, but executives said a decision on a new tissue facility would be delayed as they assess trade uncertainty and rising costs. Kruger Products generated revenue of CAD 589.7 million in the third quarter of 2026,

Teva Pharmaceutical Industries (NYSE:TEVA) outlined plans to grow its innovative medicines business and advance a pipeline spanning neuroscience, immunology and cancer treatments at its first R&D Day. President and CEO Richard Francis said Teva expects $3.8 billion to $3.92 billion in innovativ

Crypto's latest shock has exposed a bigger question about earnings. Discover what's changing inside this exchange, where future growth could come from, and the risks investors can't afford to ignore.

This Canadian dividend stock’s attractive 4.9% dividend yield and ambitious growth plans make it look undervalued for long-term investors, especially after its recent share price pullback.

Telus is reducing debt, targeting $900 million in cost savings, and investing in fibre and AI infrastructure.

Let's remind ourselves what Unity Software does and then consider the potential buyout.

Costco is a high-quality business at an ultra-premium price.

It has closed higher in 55 of the past 76 years. So why did it fall the last two times?

Merger savings and fee cuts set up a new phase for shareholders.

Vertex Pharmaceuticals earns steady profits from its cystic fibrosis medicines while expanding into new diseases. BioNTech has a large cash cushion and a growing cancer pipeline, but its COVID vaccine sales are fading.

Given their reliable dividend payouts, high yield, and healthy growth prospects, these two monthly-paying dividend stocks are ideal for income-seeking retirees.

Freehold supplies more starting income, while Whitecap offers a different route through production growth.

Debt rose to $210 million after the Orion deal, yet management expects leverage to fall quickly as cash flow grows.

DocuSign is widening its reach beyond e-signatures, while ServiceNow's AI push has fueled faster growth, though one trades at a clear valuation premium.

Shopify Inc (TSX:SHOP) stock has delivered large returns. Those who cashed out TFSA SHOP positions may have more room than they think.

Enbridge is one of Canada's best-known dividend stocks with an attractive 5.8% yield. Here's how to earn $500/quarter by owning the stock.

Controlled test markets let Reed's measure whether new products sell through before committing to a national launch, a test of its growth plan.

AAON posted a Q3 earnings and revenue beat driven by surging BASX data center cooling sales, raised 2026 sales guidance, but also disclosed a material weakness requiring restated results.

Operating cash turned positive for the first time this year as IoT grew.

Execution speed, not contract signings alone, determines when Hut 8's power-backed leases turn into cash, and that timing is the real test for shareholders.